Scholarly article on Toluene-4-sulfonic acid (3aS,4R,5S,6aR)-4-methoxymethyl-2-oxo-hexahydro-cyclopenta[b]furan-5-yl ester 39749-39-8 from Journal of the American Chemical Society p. 5876,5890

DOI: 10.1021/ja00825a028

Source and publish data:

Journal of the American Chemical Society p. 5876,5890 (1974)

Update date:2022-07-28

Topics:

Authors:

Cooper Cooper

Yankee Yankee

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00825a028

Full text of DOI:10.1021/ja00825a028

Products guided by the article

Product name:Toluene-4-sulfonic acid (3aS,4R,5S,6aR)-4-methoxymethyl-2-oxo-hexahydro-cyclopenta[b]furan-5-yl ester

Cas No:39749-39-8

R&D Labs maybe for 39749-39-8

Suzhou Chiral Pharmaceuticals Co., Ltd.

Contact:86-0512-63197058

Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
C-LAB Chemievermittlung GmbH

Contact:+49-9398-993127

Address:Untertorstr. 27
Huaian Double Win Chemicals Co.,Ltd.

Contact:+86-13511538872

Address:Blk 43,Greenland Century Town,Huaian District, Huaian City,Jiangsu Province,China
Zhejiang kehong chemical co., ltd

Contact:0086-575-85522000

Address:xiner center RD binhai industrial zone shaoxing zhejiang province P.R.China,312073
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)

Contact:021-52217366

Address:shanghai

Relevant to this article

The versatility of α-chloropropargyl phenyl sulfide affords high stereo- and regioselectivities in indium-promoted coupling reactions under mild conditions

Doi:10.1021/jo015992l
(2002)
Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis

Doi:10.1021/jm050076b
(2005)
Synthesis of novel pyrazolopyrrolopyrazines, potential analogs of sildenafil

Doi:10.1002/jhet.5570380506
(2001)
Intramolecular dehydration of mannitol in high-temperature liquid water without acid catalysts

Doi:10.1039/c4ra09198a
(2014)
Doi:10.1055/s-1972-21936
(1972)
Oxidosqualene cyclase (OSC) inhibitors for the treatment of dyslipidemia

Doi:10.2533/000942905777676858
(2005)

Article Doi

DOI: 10.1021/ja00825a028